This is not the most recent version of the article. View current version (16 SEP 2015)

Intervention Review

You have free access to this content

Rutosides for prevention of post-thrombotic syndrome

  1. Joanne R Morling1,
  2. Su Ern Yeoh2,
  3. Dinanda N Kolbach3,*

Editorial Group: Cochrane Peripheral Vascular Diseases Group

Published Online: 30 APR 2013

Assessed as up-to-date: 9 OCT 2012

DOI: 10.1002/14651858.CD005626.pub2


How to Cite

Morling JR, Yeoh SE, Kolbach DN. Rutosides for prevention of post-thrombotic syndrome. Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD005626. DOI: 10.1002/14651858.CD005626.pub2.

Author Information

  1. 1

    University of Edinburgh, Centre for Population Health Sciences, Edinburgh, UK

  2. 2

    University of Edinburgh, College of Medicine and Veterinary Medicine, Edinburgh, UK

  3. 3

    Landgraaf, Netherlands

*Dinanda N Kolbach, Strijthagerweg 15, Landgraaf, 6372 AC, Netherlands. Dinanda.Kolbach@maastrichtuniversity.nl. dinanda@kolbachkliniek.nl.

Publication History

  1. Publication Status: New
  2. Published Online: 30 APR 2013

SEARCH

This is not the most recent version of the article. View current version (16 SEP 2015)

References

References to studies excluded from this review

  1. References to studies excluded from this review
  2. Additional references
Monreal 1997 {published data only}
  • Monreal M, Callejas JM, Martorell A, Sahuquillo JC, Contel E. Prevention of post-thrombotic syndrome with hidrosmina: A prospective pilot study. Phlebology 1997;12(1):21-4.

Additional references

  1. References to studies excluded from this review
  2. Additional references
Bombardelli 1996
  • Bombardelli E, Morazzoni P, Griffini A. Aesculus hippocastanum L. Fitoterapia 1996;67(6):483-511.
Cesarone 2005
  • Cesarone MR, Belcaro G, Pellegrini L, Ledda A, Vinciguerra G, Ricci A, et al. HR, 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study. Angiology 2005;56(2):165-72.
Facino 1995
  • Facino RM, Carini M, Stefani R, Aldini G, Saibene L. Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency. Archiv der Pharmazie 1995;328(10):720-4.
Guillaume 1994
  • Guillaume M, Padioleau F. Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. Arzneimittelforschung 1994;44(1):25-35.
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available form www.cochrane-handbook.org. The Cochrane Collaboration.
Iafrati 1994
  • Iafrati MD, Welch H, O'Donnell TF, Belkin M, Umphrey S, McLaughlin R. Correlation of venous noninvasive tests with the Society of Vascular Surgery/International Society for Cardiovascular Surgery clinical classification of chronic venous insufficiency. Journal of Vascular Surgery 1994;19(6):1001-7.
Kolbach 2004
  • Kolbach DN, Sandbrink MWC, Hamulyak K, Prins MH, Neumann MHAM. Non-pharmaceutical measures for prevention of post-thrombotic syndrome. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD004174.pub2]
Lorenz 1960
Meissner 2002
  • Meissner MH, Zierler BK, Bergelin RO, Chandler WL, Strandness DE Jr. Coagulation, fibrinolysis, and recanalization after acute deep venous thrombosis. Journal of Vascular Surgery 2002;35(2):278-85.
Morling 2013
  • Morling JR, Yeoh SE, Kolbach DN. Rutosides for the treatment of post-thrombotic syndrome. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD005625]
Moyses 1987
  • Moyses C, Cederholm-Williams SA, Michel CC. Haemoconcentration and accumulation of white cells in the feet during venous stasis. International Journal of Microcirculation: Clinical and Experimental 1987;5(4):311-20.
Partsch 1991
Pittler 2006
Prandoni 1996
Sarin 1993
  • Sarin S, Andaz A, Shields DA, Scurr JH, Coleridge Smith PD. Neutrophil activation in venous disease. Journal of Vascular Surgery 1993;17:444.
Schrader 1995
  • Schrader E, Schwankl W, Sieder C, Christoffel V. Comparison of the bioavailability of beta-aescin after single oral administration of two different drug formulations containing an extract of horse-chestnut seeds [Vergleichende Untersuchung zur Bioverfügbarkeit von ß-Aescin nach oraler Einmalverabreichung zweier Rosskastaniensamenextrakt enthaltender, galenisch unterschiedlicher Darreichungsformen]. Pharmazie 1995;50(9):623-7.
Thomas 1988
  • Thomas PR, Nash GB, Dormandy JA. White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. BMJ 1988;296(6638):1693-5.
Widmer 1985
  • Widmer LK, Zemp E, Widmer TM, Schmitt HE, Brandenberg E, Voelin R, et al. Late results in deep vein thrombosis of the lower extremity. Vasa 1985;14(3):264-8.